Page last updated: 2024-10-27

fluorouracil and Telangiectasia, Hereditary Hemorrhagic

fluorouracil has been researched along with Telangiectasia, Hereditary Hemorrhagic in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Telangiectasia, Hereditary Hemorrhagic: An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
de Jel, DVC1
Disch, FJM1
Kroon, S1
Mager, JJ1
Verdam, FJ1
Flieger, D1
Hainke, S1
Fischbach, W1

Other Studies

2 other studies available for fluorouracil and Telangiectasia, Hereditary Hemorrhagic

ArticleYear
Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia.
    Angiogenesis, 2020, Volume: 23, Issue:3

    Topics: Administration, Intranasal; Adult; Aged; Epistaxis; Female; Fluorouracil; Humans; Male; Middle Aged;

2020
Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab.
    Annals of hematology, 2006, Volume: 85, Issue:9

    Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Hu

2006